Compare GT & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GT | LMAT |
|---|---|---|
| Founded | 1898 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2005 | 2006 |
| Metric | GT | LMAT |
|---|---|---|
| Price | $6.52 | $81.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $9.13 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 8.3M | 348.0K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | ★ $18,280,000,000.00 | $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | $3.06 | $8.88 |
| P/E Ratio | ★ N/A | $56.92 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $5.43 | $78.65 |
| 52 Week High | $10.62 | $118.01 |
| Indicator | GT | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 46.45 | 31.43 |
| Support Level | $6.66 | N/A |
| Resistance Level | $6.78 | $89.00 |
| Average True Range (ATR) | 0.32 | 4.11 |
| MACD | -0.07 | -2.06 |
| Stochastic Oscillator | 25.93 | 7.86 |
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific. The majority of its revenue is generated from the Americas business, which develops, manufactures, distributes, and sells tires and related products and services in North, Central, and South America, along with selling tires to various export markets, mainly through intersegment sales.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.